Maturation of marginal zone and follicular B cells requires B cell activating factor of the tumor necrosis factor family and is independent of B cell maturation antigen - PubMed (original) (raw)
Maturation of marginal zone and follicular B cells requires B cell activating factor of the tumor necrosis factor family and is independent of B cell maturation antigen
P Schneider et al. J Exp Med. 2001.
Abstract
B cells undergo a complex series of maturation and selection steps in the bone marrow and spleen during differentiation into mature immune effector cells. The tumor necrosis factor (TNF) family member B cell activating factor of the TNF family (BAFF) (BLyS/TALL-1) plays an important role in B cell homeostasis. BAFF and its close homologue a proliferation-inducing ligand (APRIL) have both been shown to interact with at least two receptors, B cell maturation antigen (BCMA) and transmembrane activator and cyclophilin ligand interactor (TACI), however their relative contribution in transducing BAFF signals in vivo remains unclear. To functionally inactivate both BAFF and APRIL, mice transgenic for a soluble form of TACI were generated. They display a developmental block of B cell maturation in the periphery, leading to a severe depletion of marginal zone and follicular B2 B cells, but not of peritoneal B1 B cells. In contrast, mice transgenic for a soluble form of BCMA, which binds APRIL, have no detectable B cell phenotype. This demonstrates a crucial role for BAFF in B cell maturation and strongly suggests that it signals via a BCMA-independent pathway and in an APRIL-dispensable way.
Figures
Figure 1.
Generation of TACI:Fc and BCMA:Fc transgenic mice. (A) Constructs used for the generation of transgenic mouse. AAT, human α1-antitrypsin promoter; Fc, human IgG1 linker, CH2, and CH3 domains; SP, Ig heavy chain signal peptide. Intron and poly A addition sequences were from rabbit β-globin gene. (B) Genomic screen of transgenic mice. The 252-bp band amplified by PCR is specific for human α1-anti-trypsin promoter. (C) Western blot analysis of transgene expression. Serum (0.5 μl) of two independent lines of each TACI:Fc and BCMA:Fc transgenic mice and of nontransgenic controls were analyzed under nonreducing conditions and revealed with horseradish peroxidase–coupled goat anti–human IgG antibody. Recombinant proteins (6 ng of BCMA:Fc and 12 ng of TACI:Fc) in normal serum were loaded as standard. For transgenic mice, the serum concentration of the transgenic protein is indicated. Molecular weight standard are in kDa. (D) Receptor-ligand interaction ELISA. Binding of recombinant murine BAFF (black circles), murine APRIL (white circles), or control murine TNF-α (white diamonds) to immobilized recombinant or transgenic BCMA:Fc and TACI:Fc was monitored by ELISA.
Figure 1.
Generation of TACI:Fc and BCMA:Fc transgenic mice. (A) Constructs used for the generation of transgenic mouse. AAT, human α1-antitrypsin promoter; Fc, human IgG1 linker, CH2, and CH3 domains; SP, Ig heavy chain signal peptide. Intron and poly A addition sequences were from rabbit β-globin gene. (B) Genomic screen of transgenic mice. The 252-bp band amplified by PCR is specific for human α1-anti-trypsin promoter. (C) Western blot analysis of transgene expression. Serum (0.5 μl) of two independent lines of each TACI:Fc and BCMA:Fc transgenic mice and of nontransgenic controls were analyzed under nonreducing conditions and revealed with horseradish peroxidase–coupled goat anti–human IgG antibody. Recombinant proteins (6 ng of BCMA:Fc and 12 ng of TACI:Fc) in normal serum were loaded as standard. For transgenic mice, the serum concentration of the transgenic protein is indicated. Molecular weight standard are in kDa. (D) Receptor-ligand interaction ELISA. Binding of recombinant murine BAFF (black circles), murine APRIL (white circles), or control murine TNF-α (white diamonds) to immobilized recombinant or transgenic BCMA:Fc and TACI:Fc was monitored by ELISA.
Figure 1.
Generation of TACI:Fc and BCMA:Fc transgenic mice. (A) Constructs used for the generation of transgenic mouse. AAT, human α1-antitrypsin promoter; Fc, human IgG1 linker, CH2, and CH3 domains; SP, Ig heavy chain signal peptide. Intron and poly A addition sequences were from rabbit β-globin gene. (B) Genomic screen of transgenic mice. The 252-bp band amplified by PCR is specific for human α1-anti-trypsin promoter. (C) Western blot analysis of transgene expression. Serum (0.5 μl) of two independent lines of each TACI:Fc and BCMA:Fc transgenic mice and of nontransgenic controls were analyzed under nonreducing conditions and revealed with horseradish peroxidase–coupled goat anti–human IgG antibody. Recombinant proteins (6 ng of BCMA:Fc and 12 ng of TACI:Fc) in normal serum were loaded as standard. For transgenic mice, the serum concentration of the transgenic protein is indicated. Molecular weight standard are in kDa. (D) Receptor-ligand interaction ELISA. Binding of recombinant murine BAFF (black circles), murine APRIL (white circles), or control murine TNF-α (white diamonds) to immobilized recombinant or transgenic BCMA:Fc and TACI:Fc was monitored by ELISA.
Figure 1.
Generation of TACI:Fc and BCMA:Fc transgenic mice. (A) Constructs used for the generation of transgenic mouse. AAT, human α1-antitrypsin promoter; Fc, human IgG1 linker, CH2, and CH3 domains; SP, Ig heavy chain signal peptide. Intron and poly A addition sequences were from rabbit β-globin gene. (B) Genomic screen of transgenic mice. The 252-bp band amplified by PCR is specific for human α1-anti-trypsin promoter. (C) Western blot analysis of transgene expression. Serum (0.5 μl) of two independent lines of each TACI:Fc and BCMA:Fc transgenic mice and of nontransgenic controls were analyzed under nonreducing conditions and revealed with horseradish peroxidase–coupled goat anti–human IgG antibody. Recombinant proteins (6 ng of BCMA:Fc and 12 ng of TACI:Fc) in normal serum were loaded as standard. For transgenic mice, the serum concentration of the transgenic protein is indicated. Molecular weight standard are in kDa. (D) Receptor-ligand interaction ELISA. Binding of recombinant murine BAFF (black circles), murine APRIL (white circles), or control murine TNF-α (white diamonds) to immobilized recombinant or transgenic BCMA:Fc and TACI:Fc was monitored by ELISA.
Figure 2.
FACS® analysis of lymphoid organs of TACI:Fc and BCMA:Fc transgenic mice. The indicated percentages refer to gated lymphocytes. (A) Bone marrow. Lymphocytes expressing the B cell lineage marker B220 were separated according to CD43 expression and further analyzed with CD24 and BP-1 (for CD43+ cells) and IgM and IgD (for CD43− cells). Populations A (pre-pro-B), B (pro-B), C (pro-B/PreB), D (pre-B), E (transitional B), and F (recirculating mature B) are labeled according to Hardy's nomenclature (reference 29). (B) Spleen. Analysis of splenic B (B220+) and T (CD3+) cell populations, and four color FACS® analysis of splenic B cell populations based on B220, CD23, CD21, and surface IgM expression (references 2 and 18). FO, follicular B cells; MZ, marginal zone B cells; T1, transitional T1 B cells; T2, transitional T2 B cells. (C) Inguinal lymph nodes. Analysis of B cell populations based on B220 and IgD. (D) Peripheral blood lymphocytes. Analysis of B cell populations based on the expression of B220, CD62L (L-selectin), and CD21. (E) Peritoneal exudate lymphocytes. Peritoneal B lymphocytes are classified into B1 and B2 cells based on the expression level of CD23, and further analyzed for CD5 and IgM expression. B1a, CD5+ B1 B cells; B1b, CD5− B1 B cells. (F) Thymus. Thymocytes are analyzed based on the expression of CD4, CD8, TCR-αβ, and TCR-γδ. ISP, immature CD8 single positive precursor T cells; NKT, NK T cells.
Figure 3.
Immunohistochemistry of frozen spleen, lymph node, and Peyer's patches sections. Spleen. Serial sections were double stained with B cells (anti-B220, brown), T cells (anti-CD3ε, purple), follicular dendritic cells (anti-CD35/Cr1, purple), macrophages (CD11b, brown) and dendritic cells (CD11c, purple) markers, as indicated. Inguinal lymph nodes and Peyer's patches were doubly stained for B and T cells. Peyer's patches were present in normal number in TACI:Fc mice, but had a smaller size. Bars = 100 μm.
Figure 4.
Reduced Ig levels in TACI:Fc mice. Ig levels were determined in normal serum of TACI:Fc transgenic mice and matched control littermates. P values: *0.2 > P ≥ 0.05; **0.05 > P ≥ 0.01; ***P < 0.01.
Similar articles
- Selectivity of BAFF/BLyS and APRIL for binding to the TNF family receptors BAFFR/BR3 and BCMA.
Day ES, Cachero TG, Qian F, Sun Y, Wen D, Pelletier M, Hsu YM, Whitty A. Day ES, et al. Biochemistry. 2005 Feb 15;44(6):1919-31. doi: 10.1021/bi048227k. Biochemistry. 2005. PMID: 15697217 - B-cell maturation protein, which binds the tumor necrosis factor family members BAFF and APRIL, is dispensable for humoral immune responses.
Xu S, Lam KP. Xu S, et al. Mol Cell Biol. 2001 Jun;21(12):4067-74. doi: 10.1128/MCB.21.12.4067-4074.2001. Mol Cell Biol. 2001. PMID: 11359913 Free PMC article. - A soluble form of B cell maturation antigen, a receptor for the tumor necrosis factor family member APRIL, inhibits tumor cell growth.
Rennert P, Schneider P, Cachero TG, Thompson J, Trabach L, Hertig S, Holler N, Qian F, Mullen C, Strauch K, Browning JL, Ambrose C, Tschopp J. Rennert P, et al. J Exp Med. 2000 Dec 4;192(11):1677-84. doi: 10.1084/jem.192.11.1677. J Exp Med. 2000. PMID: 11104810 Free PMC article. - The uncertain glory of APRIL.
Medema JP, Planelles-Carazo L, Hardenberg G, Hahne M. Medema JP, et al. Cell Death Differ. 2003 Oct;10(10):1121-5. doi: 10.1038/sj.cdd.4401291. Cell Death Differ. 2003. PMID: 14502235 Review. - The BAFF/APRIL system: life beyond B lymphocytes.
Ng LG, Mackay CR, Mackay F. Ng LG, et al. Mol Immunol. 2005 May;42(7):763-72. doi: 10.1016/j.molimm.2004.06.041. Epub 2004 Dec 8. Mol Immunol. 2005. PMID: 15829264 Review.
Cited by
- Cellular indexing of transcriptomes and epitopes (CITE-Seq) in hidradenitis suppurativa identifies dysregulated cell types in peripheral blood and facilitates diagnosis via machine learning.
Kumar S, Orcales F, Shih BB, Fang X, Yin C, Yates A, Dimitrion P, Neuhaus I, Johnson C, Adrianto I, Wiala A, Hamzavi I, Zhou L, Naik H, Posch C, Mi QS, Liao W. Kumar S, et al. Res Sq [Preprint]. 2024 Sep 9:rs.3.rs-4791069. doi: 10.21203/rs.3.rs-4791069/v1. Res Sq. 2024. PMID: 39315268 Free PMC article. Preprint. - An unappreciated cell survival-independent role for BAFF initiating chronic lymphocytic leukemia.
Ullah MA, Garcillán B, Whitlock E, Figgett WA, Infantino S, Eslami M, Yang S, Rahman MA, Sheng YH, Weber N, Schneider P, Tam CS, Mackay F. Ullah MA, et al. Front Immunol. 2024 Feb 26;15:1345515. doi: 10.3389/fimmu.2024.1345515. eCollection 2024. Front Immunol. 2024. PMID: 38469292 Free PMC article. - The bidirectional immune crosstalk in metabolic dysfunction-associated steatotic liver disease.
Sawada K, Chung H, Softic S, Moreno-Fernandez ME, Divanovic S. Sawada K, et al. Cell Metab. 2023 Nov 7;35(11):1852-1871. doi: 10.1016/j.cmet.2023.10.009. Cell Metab. 2023. PMID: 37939656 Review. - The BAFF-APRIL System in Cancer.
Ullah MA, Mackay F. Ullah MA, et al. Cancers (Basel). 2023 Mar 16;15(6):1791. doi: 10.3390/cancers15061791. Cancers (Basel). 2023. PMID: 36980677 Free PMC article. Review. - Pattern recognition receptor ligand-induced differentiation of human transitional B cells.
McMillan JKP, O'Donnell P, Chang SP. McMillan JKP, et al. PLoS One. 2022 Aug 30;17(8):e0273810. doi: 10.1371/journal.pone.0273810. eCollection 2022. PLoS One. 2022. PMID: 36040923 Free PMC article.
References
- Hardy, R.R., and K. Hayakawa. 2001. B cell development pathways. Annu. Rev. Immunol. 19:595–621. - PubMed
- Rolink, A.G., C. Schaniel, J. Andersson, and F. Melchers. 2001. Selection events operating at various stages in B cell development. Curr. Opin. Immunol. 13:202–207. - PubMed
- Fagarasan, S., and T. Honjo. 2000. T-Independent immune response: new aspects of B cell biology. Science. 290:89–92. - PubMed
- Macpherson, A.J., D. Gatto, E. Sainsbury, G.R. Harriman, H. Hengartner, and R.M. Zinkernagel. 2000. A primitive T cell-independent mechanism of intestinal mucosal IgA responses to commensal bacteria. Science. 288:2222–2226. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
Research Materials
Miscellaneous